Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianne Paesmans

Showing results (1-10 of 158) with videos related to

Pageof 16
Sort By:
Current Opinion in Oncology|July 20, 2002
Benefits of chemotherapy for quality of life in patients with advanced nonsmall-cell lung cancerMarianne Paesmans
The European Respiratory Journal|November 2, 2015
Should the treatment of advanced lepidic adenocarcinoma be adapted to the pathological subtype?Marianne Paesmans
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2001
Antifungal prophylaxis and the rate of bacteremia among neutropenic patientsClaudio Viscoli, Marianne Paesmans,
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 13, 2006
Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infectionJean Klastersky, Marianne Paesmans
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2006
Are we cautious enough when we interpret results of randomized but underpowered comparisons?Marianne Paesmans, Harry Bleiberg
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 13, 2007
Risk-adapted strategy for the management of febrile neutropenia in cancer patientsJean Klastersky, Marianne Paesmans,
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 28, 2013
The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patientsJean Klastersky, Marianne Paesmans
Onkologie|May 18, 2011
Treatment of febrile neutropenia is expensive: prevention is the answerJean A Klastersky, Marianne Paesmans
Biomarkers in Medicine|September 15, 2016
Biomarkers for adverse events associated with immune checkpoint inhibitorsHampig Raphael Kourie, Marianne Paesmans, Jean Klastersky
Therapeutic Advances in Medical Oncology|September 10, 2011
Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variablesThierry Berghmans, Marianne Paesmans, Jean-Paul Sculier
Pageof 16

Showing results (1-10 of 158) with videos related to

Sort By:
Pageof 16
Current Opinion in Oncology|July 20, 2002
Benefits of chemotherapy for quality of life in patients with advanced nonsmall-cell lung cancerMarianne Paesmans
The European Respiratory Journal|November 2, 2015
Should the treatment of advanced lepidic adenocarcinoma be adapted to the pathological subtype?Marianne Paesmans
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2001
Antifungal prophylaxis and the rate of bacteremia among neutropenic patientsClaudio Viscoli, Marianne Paesmans,
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 13, 2006
Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infectionJean Klastersky, Marianne Paesmans
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2006
Are we cautious enough when we interpret results of randomized but underpowered comparisons?Marianne Paesmans, Harry Bleiberg
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 13, 2007
Risk-adapted strategy for the management of febrile neutropenia in cancer patientsJean Klastersky, Marianne Paesmans,
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 28, 2013
The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patientsJean Klastersky, Marianne Paesmans
Onkologie|May 18, 2011
Treatment of febrile neutropenia is expensive: prevention is the answerJean A Klastersky, Marianne Paesmans
Biomarkers in Medicine|September 15, 2016
Biomarkers for adverse events associated with immune checkpoint inhibitorsHampig Raphael Kourie, Marianne Paesmans, Jean Klastersky
Therapeutic Advances in Medical Oncology|September 10, 2011
Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variablesThierry Berghmans, Marianne Paesmans, Jean-Paul Sculier
Pageof 16